Macromoltek

Biotech · Private

Computational platform for automated design of humanized antibodies using machine learning and structural biology algorithms

Grants
$1.4M
2 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
4
1 granted · 3 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantNational Science Foundation · Phase I · SBIR Phase I: Automated Humanization of Antibodies Directed to Protein and Carbohydrate Antigens$178,700
Federal grantNational Science Foundation · Phase II · SBIR Phase II: Automated Design Methods of Antibodies Directed to Protein and Carbohydrate Antigens$1,193,494
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1568COGNITION THERAPEUTICS, INC.—$23M
1569ASYSTBIO LABORATORIES, LLC——
1570REPROTOX BIOTECH, LLC——
1571Macromoltek——
1572Coultreon Biopharma——
1573NANORED LLC——
1574GENELUX Corp—$24M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 1 granted of 4
  • ASTROTACTIN1-BASED Compositions And Pharmaceutical Formulationsapplication
  • ASTROTACTIN1-BASED Compositions And Pharmaceutical Formulationsgranted
  • Computational Methods For Analysis And Molecular Design Of Antibodies, Antibody Humanization, And Epitope Mapping Coupled To A User-interactive Web Browser With Embedded Three- Dimensional Renderingapplication
  • Compositions And Methods For Treating Progressive Neurodegenerative Diseasesapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.